clofazimine has been researched along with cyclosporine in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (43.75) | 18.2507 |
| 2000's | 2 (12.50) | 29.6817 |
| 2010's | 6 (37.50) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Casciano, CN; Clement, RP; Johnson, WW; Wang, EJ | 2 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Aleo, MD; Bonin, PD; Luo, Y; Potter, DM; Swiss, R; Will, Y | 1 |
| Delabio, LC; Dutra, JP; Hembecker, M; Kita, DH; Moure, VR; Pereira, GDS; Scheiffer, G; Valdameri, G; Zattoni, IF | 1 |
| Bahmer, FA | 1 |
| Dann, FJ; Frankel, RI; Kim, R; Mita, RT | 1 |
| Anderson, R; Jooné, GK; Myer, MS; O'Sullivan, JF; Van Rensburg, CE | 1 |
| Altes-Levy, HR; Chin-a-Lien, RA; Naafs, B | 1 |
| Anderson, R; Prinsloo, Y; van der Walt, R; van Rensburg, CE | 1 |
| Naafs, B | 1 |
| Anderson, R; Jooné, G; Van Rensburg, CE | 1 |
| Bonsmann, G; Kuhn, A; Ruland, V | 1 |
| Colley, BS; Phillips, LL; Reeves, TM; Trimmer, PA | 1 |
3 review(s) available for clofazimine and cyclosporine
| Article | Year |
|---|---|
Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Breast Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Neoplasm Proteins; Neoplastic Stem Cells | 2022 |
Bangkok Workshop on Leprosy Research. Treatment of reactions and nerve damage.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Clofazimine; Cyclosporine; Drug Administration Schedule; Erythema Nodosum; Humans; Hypersensitivity, Delayed; Immunosuppressive Agents; Leprostatic Agents; Leprosy; Leprosy, Lepromatous; Peripheral Nervous System Diseases; Prednisolone; Prednisone; Thalidomide | 1996 |
Cutaneous lupus erythematosus: update of therapeutic options part II.
Topics: Algorithms; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Clofazimine; Cyclophosphamide; Cyclosporine; Dapsone; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interferon-alpha; Isoxazoles; Leflunomide; Lenalidomide; Lupus Erythematosus, Cutaneous; Methotrexate; Mycophenolic Acid; Retinoids; Rituximab; Thalidomide; Tumor Necrosis Factor-alpha | 2011 |
13 other study(ies) available for clofazimine and cyclosporine
| Article | Year |
|---|---|
Active transport of fluorescent P-glycoprotein substrates: evaluation as markers and interaction with inhibitors.
Topics: 3T3 Cells; Adrenergic Uptake Inhibitors; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding Sites; Biological Transport, Active; Cell Line; Cell Separation; Cell Survival; Flow Cytometry; Fluorescent Dyes; Humans; Inhibitory Concentration 50; Mice; Protein Binding; Reserpine; Spectrometry, Fluorescence; Substrate Specificity; Time Factors | 2001 |
Fluorescent substrates of sister-P-glycoprotein (BSEP) evaluated as markers of active transport and inhibition: evidence for contingent unequal binding sites.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Binding Sites; Biological Transport, Active; Biomarkers; Cells, Cultured; Drug Interactions; Fluorescent Dyes; Humans | 2003 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Chemical and Drug Induced Liver Injury; Humans; Male; Mitochondria, Liver; Rats; Rats, Sprague-Dawley; Severity of Illness Index | 2014 |
[Therapy of lymphocytic infiltration].
Topics: Azathioprine; Clofazimine; Cyclosporine; Dapsone; Humans; Levamisole; Lymphocytosis; Skin; Skin Diseases; Thalidomide | 1992 |
Resolution of type 1 reaction in multibacillary Hansen's disease as a result of treatment with cyclosporine.
Topics: Adult; Clofazimine; Cyclosporine; Drug Therapy, Combination; Humans; Leprosy, Borderline; Male; Rifampin; Skin | 1992 |
The riminophenazine agents clofazimine and B669 reverse acquired multidrug resistance in a human lung cancer cell line.
Topics: Anti-Infective Agents; Antineoplastic Agents; Carbon Radioisotopes; Carcinoma, Small Cell; Cell Division; Clofazimine; Cyclosporine; Drug Interactions; Drug Resistance, Multiple; Humans; Lung Neoplasms; Tumor Cells, Cultured; Vinblastine | 1994 |
Midborderline (BB)-borderline lepromatous (BL) leprosy with reversal reaction (RR).
Topics: Aged; Biopsy; Clofazimine; Cyclosporine; Dapsone; Diabetes Complications; Humans; Leprosy, Lepromatous; Male; Neurologic Examination; Prednisone; Rifampin | 1994 |
Augmentative inhibition of lymphocyte proliferation by cyclosporin A combined with the riminophenazine compounds clofazimine and B669.
Topics: Adenosine Triphosphate; Adult; Arachidonic Acid; Clofazimine; Cyclosporine; Drug Synergism; Humans; Immunosuppressive Agents; Lymphocyte Activation; Lysophosphatidylcholines; Sodium-Potassium-Exchanging ATPase | 1995 |
Alpha-tocopherol antagonizes the multidrug-resistance-reversal activity of cyclosporin A, verapamil, GF120918, clofazimine and B669.
Topics: Acridines; Cell Death; Clofazimine; Cyclosporine; Drug Resistance, Multiple; Humans; Isoquinolines; Lung Neoplasms; Tetrahydroisoquinolines; Tumor Cells, Cultured; Verapamil; Vinblastine; Vitamin E | 1998 |
Targeting Kv1.3 channels to reduce white matter pathology after traumatic brain injury.
Topics: Action Potentials; Animals; Animals, Newborn; Brain Injuries, Traumatic; Calcium-Binding Proteins; Cells, Cultured; Clofazimine; Corpus Callosum; Cyclosporine; Disease Models, Animal; Electric Stimulation; Gene Expression Regulation; Immunosuppressive Agents; Kv1.3 Potassium Channel; Leukoencephalopathies; Male; Mice; Mice, Inbred C57BL; Microfilament Proteins; Potassium Channel Blockers; Rats; Rats, Sprague-Dawley; Tacrolimus | 2016 |